Skip to content
Inciteful Med

The Long-Term Journey: Survivorship and Ongoing Care

Last updated:

Long-term care for congenital hyperinsulinism (CHI) shifts from crisis management to ongoing monitoring. Key priorities include protecting brain development, screening for a potential transition from low blood sugar to diabetes, and finding support for caregiver burnout and anxiety.

Key Takeaways

  • • Severe hypoglycemia in early childhood can lead to lasting neurodevelopmental issues, requiring regular pediatric neurology evaluations.
  • • Children with specific genetic mutations or a history of pancreatic surgery are at a high risk of developing diabetes as they grow older.
  • • A subtotal pancreatectomy can cause exocrine pancreatic insufficiency, requiring digestive enzyme replacement therapy with meals.
  • • Caregiver burnout and scan anxiety from continuous glucose monitors are common, making mental health support and community connection vital.

Managing Congenital Hyperinsulinism (CHI) is a marathon, not a sprint. While the initial diagnosis and stabilization are the most intense phases, the transition to long-term survivorship brings its own set of challenges and goals. With proactive monitoring and a dedicated care team, the focus shifts from crisis management to ensuring your child reaches their full potential [1][2].

Protecting the Developing Brain

The most significant long-term risk for children with CHI is neurodevelopmental impairment [3]. Because the brain relies on glucose and ketones for fuel, severe or frequent “lows” (hypoglycemia) in early childhood can lead to lasting injuries [1][4].

  • Risks: These can include epilepsy (seizures), cerebral palsy, and delays in speech, motor skills, or learning [3][5].
  • Early Intervention: Regular check-ups with a pediatric neurologist and a developmental pediatrician are vital. Early identification of delays allows for therapies (like physical or speech therapy) that can significantly improve outcomes [6][4].

The Biphasic Shift: From Lows to Highs

For some children, the risk of low blood sugar eventually turns into a risk of high blood sugar (diabetes). This is especially true for those with specific genetic variants or surgical histories:

  • HNF4A & HNF1A Mutations: These are “biphasic” conditions. Hypoglycemia often occurs in the neonatal period, but as the child grows, the pancreas may gradually lose its ability to produce enough insulin, leading to MODY (Maturity-Onset Diabetes of the Young) [7][8]. This transition often happens around puberty but is highly variable [7][9].
  • Post-Surgical Risks: If your child had a subtotal pancreatectomy, the risk of developing insulin-dependent diabetes is high—up to 75% in some groups [10][11]. These children also face exocrine pancreatic insufficiency, meaning their body doesn’t produce the enzymes needed to digest food [12]. This can cause oily stools, bloating, and poor growth, and is managed with replacement enzymes taken with meals [13][14].

Managing the “Caregiver Burden”

The stress of constant glucose monitoring and the fear of a “silent low” can lead to significant psychological burnout [15][2].

  • Scan Anxiety and CGMs: Using Continuous Glucose Monitors (CGMs) has revolutionized care by reducing the need for constant finger pokes, but it also introduces “Scan Anxiety.” It is completely normal to feel a spike in adrenaline every time you check the CGM app or the monitor alarms [2].
  • Find Your Community: Organizations like Congenital Hyperinsulinism International (CHI) provide a lifeline, connecting families with experts and peers who understand the daily reality of this condition [2].

Long-Term Monitoring Checklist

A comprehensive follow-up plan should include:

  • [ ] Endocrinology: Regular monitoring of blood sugar trends and screening for diabetes (HbA1c or glucose tolerance tests) [6][8].
  • [ ] Neurology & Development: Formal assessments every 6-12 months in early childhood to track milestones and screen for seizures [6][4].
  • [ ] Nutrition & Digestion: Monitoring growth and looking for signs of enzyme deficiency, especially after pancreatic surgery [16][13].
  • [ ] Ophthalmology: Some forms of CHI are associated with vision issues that require regular screening [6].
  • [ ] Mental Health: Psychosocial support for both the child and the caregivers to manage the chronic stress of the condition [2][17].

Frequently Asked Questions

What are the long-term effects of congenital hyperinsulinism on the brain?
Severe or frequent low blood sugar in early childhood can lead to neurodevelopmental impairments. This may include epilepsy, cerebral palsy, or delays in speech, motor skills, and learning, making early intervention and regular neurology check-ups essential.
Will my child with congenital hyperinsulinism eventually develop diabetes?
Some children with CHI may develop diabetes later in life, a transition known as a biphasic shift. This is particularly common in children with specific genetic mutations like HNF4A or HNF1A, or those who have had a subtotal pancreatectomy.
What are the signs of exocrine pancreatic insufficiency after a pancreatectomy?
Exocrine pancreatic insufficiency occurs when the body does not produce enough enzymes to digest food properly, which is a frequent complication after a subtotal pancreatectomy. Symptoms include oily stools, bloating, and poor growth, and it is managed with replacement enzymes taken with meals.
How can I manage the stress and anxiety of monitoring my child's blood sugar?
It is completely normal to experience caregiver burnout and scan anxiety from continuous glucose monitors. Connecting with advocacy groups like Congenital Hyperinsulinism International can help you find emotional support and practical tips for managing the daily stress of the condition.
What kind of doctors will my child need to see long-term for CHI?
A comprehensive long-term care team usually includes a pediatric endocrinologist to monitor blood sugar, a pediatric neurologist to track development, and specialists in nutrition, ophthalmology, and mental health.

Questions for Your Doctor

  • • When should my child have their first formal neurodevelopmental evaluation, and how often should these be repeated?
  • • If my child had a subtotal pancreatectomy, what specific signs of 'exocrine insufficiency' (malabsorption) should I be looking for?
  • • At what age do you typically start screening for diabetes in children with this specific genetic subtype or surgical history?
  • • What is the plan for transitioning from monitoring for 'lows' to monitoring for 'highs' if my child has an HNF4A mutation?
  • • Can you refer us to a pediatric neurologist who specializes in children with a history of neonatal hypoglycemia?

Questions for You

  • • How am I feeling emotionally, and do I have symptoms of 'burnout' from the constant glucose monitoring?
  • • Have I recorded my child's developmental milestones (crawling, talking, etc.) to share with the care team?
  • • Are there specific times of day or activities that consistently trigger 'scan anxiety' for me?
  • • Have I connected with other families through advocacy groups to share practical tips for daily management?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Congenital hyperinsulinism in clinical practice: From biochemical pathophysiology to new monitoring techniques.

    Martino M, Sartorelli J, Gragnaniello V, Burlina A

    Frontiers in pediatrics 2022; (10()):901338 doi:10.3389/fped.2022.901338.

    PMID: 36210928
  2. 2

    Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism.

    Raskin J, Pasquini TLS, Bose S, et al.

    Frontiers in endocrinology 2022; (13()):886552 doi:10.3389/fendo.2022.886552.

    PMID: 35573986
  3. 3

    Congenital hyperinsulinism in a newborn presenting with poor feeding.

    Mazloom K, Sanchez-Lara PA, Langston S, et al.

    SAGE open medical case reports 2022; (10()):2050313X221083174 doi:10.1177/2050313X221083174.

    PMID: 35371490
  4. 4

    Congenital hyperinsulinsim: case report and review of literature.

    Hasbaoui BE, Elyajouri A, Abilkassem R, Agadr A

    The Pan African medical journal 2020; (35()):53 doi:10.11604/pamj.2020.35.53.16604.

    PMID: 32537058
  5. 5

    [Congenital hyperinsulinism: Loss of B-cell self-control].

    Lebl J, Roženková K, Průhová Š

    Vnitrni lekarstvi 2016; (62(11 Suppl 4)):S72-76.

    PMID: 27921429
  6. 6

    Congenital hyperinsulinism: localization of a focal lesion with 18F-FDOPA positron emission tomography.

    States LJ, Becker SA, De León DD

    Pediatric radiology 2022; (52(4)):693-701 doi:10.1007/s00247-021-05206-5.

    PMID: 34668049
  7. 7

    A Novel HNF4A Mutation Causing Three Phenotypic Forms of Glucose Dysregulation in a Family.

    Chandran S, Rajadurai VS, Hoi WH, et al.

    Frontiers in pediatrics 2020; (8()):320 doi:10.3389/fped.2020.00320.

    PMID: 32670997
  8. 8

    Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood.

    Bacon S, Kyithar MP, Condron EM, et al.

    Acta diabetologica 2016; (53(6)):965-972 doi:10.1007/s00592-016-0890-9.

    PMID: 27552834
  9. 9

    Novel Treatment Options in Patients with Maturity-Onset Diabetes of the Young.

    Müssig K

    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 2025; (133(1)):51-58 doi:10.1055/a-2436-7723.

    PMID: 39379059
  10. 10

    Surgical management of medically-refractory hyperinsulinism.

    Zobel MJ, McFarland C, Ferrera-Cook CT, Padilla BE

    American journal of surgery 2020; (219(6)):947-951 doi:10.1016/j.amjsurg.2019.09.003.

    PMID: 31757439
  11. 11

    Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center.

    Warncke K, Falco F, Rabl W, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2016; (29(10)):1187-1194.

    PMID: 27682711
  12. 12

    Reassessing Pancreatectomy in Diffuse Congenital Hyperinsulinism: A Tale of 2 Brothers With Homozygous KCNJ11 Variants.

    Rafique HA, Lucas-Herald AK, Shaikh MG

    JCEM case reports 2025; (3(4)):luaf045 doi:10.1210/jcemcr/luaf045.

    PMID: 40110568
  13. 13

    Pancreatic exocrine insufficiency following pancreatic resection.

    Phillips ME

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] 2015; (15(5)):449-455 doi:10.1016/j.pan.2015.06.003.

    PMID: 26145836
  14. 14

    Thirty-day outcomes underestimate endocrine and exocrine insufficiency after pancreatic resection.

    Lim PW, Dinh KH, Sullivan M, et al.

    HPB : the official journal of the International Hepato Pancreato Biliary Association 2016; (18(4)):360-6.

    PMID: 27037206
  15. 15

    Hyperinsulinism-hyperammonemia Syndrome in an Infant with Seizures.

    Strajnar A, Tansek MZ, Podkrajsek KT, et al.

    Balkan journal of medical genetics : BJMG 2018; (21(1)):77-81 doi:10.2478/bjmg-2018-0014.

    PMID: 30425915
  16. 16

    Therapies and outcomes of congenital hyperinsulinism-induced hypoglycaemia.

    Banerjee I, Salomon-Estebanez M, Shah P, et al.

    Diabetic medicine : a journal of the British Diabetic Association 2019; (36(1)):9-21 doi:10.1111/dme.13823.

    PMID: 30246418
  17. 17

    Munchausen syndrome by proxy: a case report.

    Alkhattabi F, Bamogaddam I, Alsagheir A, et al.

    Journal of medical case reports 2023; (17(1)):148 doi:10.1186/s13256-023-03848-7.

    PMID: 37013583

This page provides educational information on long-term care and survivorship for congenital hyperinsulinism. Always consult your pediatric endocrinologist and care team for medical advice specific to your child's ongoing health needs.

Stay up to date

Get notified when new research about Congenital isolated hyperinsulinism is published.

No spam. Unsubscribe anytime.